CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
Blood sampling +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01716533
NCT01716533N/ACompleted

A Serological Study in Adult Subjects With Clostridium Difficile Infection

GlaxoSmithKline·interventional·Posted Oct 30, 2012·Updated Jun 7, 2019

In Brief

A clinical study evaluating Blood sampling and Stool sample collection for Infections, Clostridium Difficile. Completed, enrolled 57 participants across 5 sites in 2 countries.

Detailed Summary

This study aims to 1) evaluate the C. difficile-specific immune response in CDI patients and 2) explore the difference in immune response between the patients with CDI recurrence and those with a sustained clinical response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 30, 2012
Enrollment StartFeb 2, 2013
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.7 years ago

Interventions

Blood samplingprocedure

Blood sampling will be done at Day 0, at Day 14, at recurrence (if applicable) and at end of follow-up.

Stool sample collectionother

Stool samples will be collected around Day 0, around Day 14 and at recurrence (if applicable).